BLAC Chart
- 52-Week Range: $0.00 - $0.00
- Market Capitalization: $0
- Short Percentage: 0%
- Target Price: $0.00
- Shares Outstanding: 0
- Next Earnings: N/A
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Brookfield Real Assets Income Fund Inc. Announces Distribution DeclarationGlobeNewsWire | March 31st
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | March 31st
- Rubicon Receives Notice of Non-Compliance with NYSE Trading Share Price Listing RuleBusiness Wire | March 31st
- Hudson Acquisition I Corp. Announces Letter of Intent for Business CombinationGlobeNewsWire | March 31st
- NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND ANNOUNCES MONTHLY DISTRIBUTIONPRNewsWire | March 31st
- Aterian, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | March 31st
We searched over 50 sources and couldn't find any news or press releases related to Bellevue Life Sciences Acquisition Corp. Common Stock.
Here are some articles we think you might like.
Company Info
Website: N/A
Address: N/A
Sector: N/A
Industry: N/A
Full time employees: N/A
Address: N/A
Sector: N/A
Industry: N/A
Full time employees: N/A
$BLAC let's gooooooo